Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
aduro biotech
alzheimer's disease
biogen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
2
×
cancer immunotherapy
2
×
clinical trials
deals
detroit blog main
detroit top stories
eli lilly
glaxosmithkline
2
×
indiana blog main
indiana top stories
life sciences
merck
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
2
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
a2 biotherapeutics
What
bio
roundup
alliance
approval
biogen’s
biopharmaceutical
bristol
buy
calls
changing
color
companies
convo
crispr
days
drug
earlier
failures
growing
hours
kudos
leaves
littered
myers’s
nash
new
news
notifying
october
phone
price
remains
rnai
road
rouse
scientists
shorter
slumber
strategy
talk
Language
unset
Current search:
glaxosmithkline
×
startups
×
" cancer immunotherapy "
×
cancer
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More